Status: Recruiting
Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
This is a randomized, double-blinded, placebo-controlled, crossover trial that aims to 1) determine the efficacy of THC-free cannabidiol (CBD oil) in reducing the severity of agitation among participants and 2) determine whether THC-free CBD oil can reduce the burden on caregivers and increase the participants' quality of life.
Participants needed: 40
Trial details
Phase: Phase 2Age: 50-90Biological sex: AllType: InterventionalSponsor: Eastern Virginia Medical SchoolUpdated: Feb 16, 2023Locations: 1
Eligibility criteria
Males/females over 50 years old. [+6]
Diagnosis of non-AD or non-mixed dementias. [+15]